Laryngeal cancer, affecting the voice box, is a significant focus of cancer research aimed at understanding its causes, improving early detection, and refining treatment options. Researchers explore risk factors such as smoking, alcohol consumption, and exposure to certain chemicals. They investigate genetic predispositions and the role of viruses like HPV. Early diagnosis methods like imaging and biomarker tests are under scrutiny to enhance detection accuracy and timeliness. Treatment advancements include targeted therapies, immunotherapy, and precision surgery to preserve laryngeal function. Clinical trials assess novel interventions to improve patient outcomes and quality of life. Interdisciplinary collaboration drives progress, aiming for personalized approaches that address the complexities of laryngeal cancer while minimizing its impact.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States